p.113 抽出テキスト

percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Am Heart J 2017; 190: 54-63. PMID: 28760214 199. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2013; 61: 282-294. PMID: 23265332 200. Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62: 1421-1431. PMID: 23747787 201. Head SJ, Mack MJ, Holmes DR, et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2012; 41: 535- 541. PMID: 22219412 202. Kim YH, Park DW, Lee JY, et al. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease. Circulation 2011; 123: 2373-2381. PMID: 21576650 203. Toth G, De Bruyne B, Casselman F, et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation 2013; 128: 1405-1411. PMID: 23985788 204. Sobolev BG, Fradet G, Kuramoto L, et al. The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: a population-based observational study. J Cardiothorac Surg 2013; 8: 74. PMID: 23577641 205. Graham MM, Knudtson ML, O'Neill BJ, et al. Canadian Cardiovascular Society Access to Care Working Group. Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. Can J Cardiol 2006; 22: 679-683. PMID: 16801998 206. Hannan EL, Samadashvili Z, Walford G, et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. JACC Cardiovasc Interv 2009; 2: 350-356. PMID: 19463449 207. Toyota T, Morimoto T, Shiomi H, et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Ad hoc vs. non-ad hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease. Circ J 2017; 81: 458-467. PMID: 28179612 208. Shah M, Gajanana D, Wheeler DS, et al. Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging? Cardiovasc Revasc Med 2017; 18: 344-348. PMID: 28285786 209. Dangas GD, George JC, Weintraub W, et al. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv 2010; 3: 1096-1099. PMID: 20965476 210. Blankenship JC, Moussa ID, Chambers CC, et al. Staging of multivessel percutaneous coronary interventions: an expert consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012; 79: 1138-1152. PMID: 22072562 211. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847. PMID: 22611136 212. Velazquez EJ, Lee KL, Jones RH, et al. STICHES Investigators. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med 2016; 374: 1511-1520. PMID: 27040723 213. Marui A, Nishiwaki N, Komiya T, et al. CREDO-Kyoto CABG Registry Cohort-2 Investigators. Comparison of 5-year outcomes after coronary artery bypass grafting in heart failure patients with versus without preserved left ventricular ejection fraction (from the CRE- DO-Kyoto CABG Registry Cohort-2). Am J Cardiol 2015; 116: 580- 586. PMID: 26092271 214. Sardi GL, Gaglia MA, Maluenda G, et al. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction. Am J Cardiol 2012; 109: 344- 351. PMID: 22112742 215. Galassi AR, Boukhris M, Toma A, et al. Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction. JACC Cardiovasc Interv 2017; 10: 2158-2170. PMID: 29055762 216. Marui A, Kimura T, Nishiwaki N, et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 2014; 114: 988-996. PMID: 25124184 217. Bangalore S, Guo Y, Samadashvili Z, et al. Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation 2016; 133: 2132-2140. PMID: 27151532 218. Velazquez EJ, Williams JB, Yow E, et al. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg 2012; 93: 523- 530. PMID: 22269720 219. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003; 145: 700-707. PMID: 12679768 220. Mishra S, Chu WW, Torguson R, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98: 608-612. PMID: 16923445 221. Perera D, Stables R, Thomas M, et al. BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010; 304: 867-874. PMID: 20736470 222. Meraj PM, Doshi R, Schreiber T, et al. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival. J Interv Cardiol 2017; 30: 256-263. PMID: 28419573 223. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69: 278-287. PMID: 27810347 224. Attaran S, Shaw M, Bond L, et al. Does off-pump coronary artery revascularization improve the long-term survival in patients with ventricular dysfunction? Interact Cardiovasc Thorac Surg 2010; 11: 442- 446. PMID: 20621997 225. Xia L, Ji Q, Song K, et al. Early clinical outcomes of on-pump beating-heart versus off-pump technique for surgical revascularization in patients with severe left ventricular dysfunction: the experience of a single center. J Cardiothorac Surg 2017; 12: 11. PMID: 28231841 226. Munos E, Calderon J, Pillois X, et al. Beating-heart coronary artery bypass surgery with the help of mini extracorporeal circulation for very high-risk patients. Perfusion 2011; 26: 123-131. PMID: 21242193 227. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51. PMID: 3594774 228. Di Donato M, Castelvecchio S, Menicanti L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail 2010; 12: 375-381. PMID: 20185429 229. Witkowski TG, ten Brinke EA, Delgado V, et al. Surgical ventricular restoration for patients with ischemic heart failure: determinants of two-year survival. Ann Thorac Surg 2011; 91: 491-498. PMID: 21256300 230. Michler RE, Rouleau JL, Al-Khalidi HR, et al. STICH Trial Investigators. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg 2013; 146: 1139- 1145.e6. PMID: 23111018 231. Latini R, Masson S, Staszewsky L, et al. Neurohormonal modulation in heart failure of ischemic etiology: correlates with left ventricular remodeling. Curr Heart Fail Rep 2006; 3: 157-163. PMID: 17129508 232. Schenk S, McCarthy PM, Starling RC, et al. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2004; 128: 38-43. PMID: 15224019 233. Di Donato M, Fantini F, Toso A, et al. Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2010; 140: 1325-1331.e2. PMID: 20381078 234. Klein MD, Herman MV, Gorlin R. A hemodynamic study of left ventricular aneurysm. Circulation 1967; 35: 614-630. PMID: 6024006 235. Kitamura S, Kay JH, Krohn BG, et al. Geometric and functional abnormalities of the left ventricle with a chronic localized noncontractile area. Am J Cardiol 1973; 31: 701-707. PMID: 4706727 236. Tulner SA, Steendijk P, Klautz RJ, et al. Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops. J Thorac Cardiovasc Surg 2006; 132: 610-620. PMID: 16935117